Trans-Tasman drug developer Aft Pharmaceuticals is targeting lucrative niche diseases its Big Pharma rivals have ignored ...

US health secretary Robert F Kennedy Jr said during a podcast interview that the Trump administration will stop government ...

Shares Biotechnology ETF offers efficient, diversified exposure to the sector's revival, balancing risk and cost for ...

Q1 company earnings painted a picture of corporate health as markets entered a period of trade tumult. Read more here.

The voluble billionaire discusses his mission to transform health care, why Kamala lost, the problem with Bluesky, and much ...

Google Veo3 creates beautiful base videos, but what if that’s not enough? I built a @ComfyUI workflow that takes it further: ...

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster ...

When you look at Kennedy, you have to see how shallow he is. There is good reason to distrust the government because we keep ...

Sure, I wee like Austin Powers and the number twos are like tennis balls – get comfortable with that idea. But I’m the best ...

Indian stock markets opened flat in the red on Friday, as global concerns once again pressured investor sentiment. The recent ...

JERSEY could soon set up its own independent medicines regulator in a move to strengthen oversight of its emerging pharmaceutical and medical cannabis industries. Health Minister Tom Binet confirmed ...

A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.